Log in to save to my catalogue

SUBACUTE TOXICITY STUDY OF T11TS: A NOVEL IMMUNOTHERAPEUTIC GLYCOPEPTIDE AGAINST GLIOMA

SUBACUTE TOXICITY STUDY OF T11TS: A NOVEL IMMUNOTHERAPEUTIC GLYCOPEPTIDE AGAINST GLIOMA

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754888275

SUBACUTE TOXICITY STUDY OF T11TS: A NOVEL IMMUNOTHERAPEUTIC GLYCOPEPTIDE AGAINST GLIOMA

About this item

Full title

SUBACUTE TOXICITY STUDY OF T11TS: A NOVEL IMMUNOTHERAPEUTIC GLYCOPEPTIDE AGAINST GLIOMA

Publisher

Jalgaon: Advances in Pharmacology and Toxicology (APT Journals)

Journal title

Advances in pharmacology and toxicology, 2010-04, Vol.11 (1), p.1-1

Language

English

Formats

Publication information

Publisher

Jalgaon: Advances in Pharmacology and Toxicology (APT Journals)

More information

Scope and Contents

Contents

T11 Target Structure (T11TS) is a cell surface glycopeptide, isolated and purified from Sheep Red Blood Cell (SRBC), with antitumor and immunostimulatory properties against induced rat glioma. For the subacute toxicity study of T11TS three doses viz., 800 mg/kg body weight, 900 mg/kg body weight and 1000 mg/kg body weight were selected. The study w...

Alternative Titles

Full title

SUBACUTE TOXICITY STUDY OF T11TS: A NOVEL IMMUNOTHERAPEUTIC GLYCOPEPTIDE AGAINST GLIOMA

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_754888275

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_754888275

Other Identifiers

ISSN

0973-2381

How to access this item